Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.


CSE:PHRX - Post by User

Pharmadrug Inc > Stop trashing each other. Let’s talk about buzz
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(15)
•••
Comment by SamRothsteinon Apr 14, 2021 9:13am
44 Views
Post# 32991581

RE:RE:RE:RE:RE:RE:Stop trashing each other. Let’s talk about buzz

RE:RE:RE:RE:RE:RE:Stop trashing each other. Let’s talk about buzz I already replied to you below.  Not sure which part of that you don't understand.  Cohen has expenses like anyone else.

Finalrep wrote:

Is the Buzz CEO in financial trouble? I mean if he believed in the company surely he would hold onto the shares and sell at a higher price right? Is he desperate?


 

 

SamRothstein wrote: Would be nice to see that, but since he sold shares as he needed funds to make up for lack of salary from startup through 2020, I am not holding my breath.  Unlike Jeff, Cohen doesn't have two CEO salaries from 2 different publicly traded companies.  He has to make do with one.
 

 

Finalrep wrote: I wonder if the CEO will scope back up his 3 million shares at 9 cents for a 25% discount? Or does he not think this the bottom yet?

 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities